4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
HCW Biologics Inc. (HCWB) operates in the Biotechnology industry and is headquartered in Miramar, United States with about 35 employees. Its market capitalization is roughly $7 million. In the fiscal year ended 2025-12-31, HCWB reported $0M in revenue and ($8M) in net income.
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States.
Interactive charts & full statements → Open the HCWB valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $3M | $3M | $7M | — |
| Gross Profit | $0M | $1M | $1M | $3M | — |
| Operating Income (EBIT) | ($11M) | ($28M) | ($26M) | ($15M) | — |
| Net Income | ($8M) | ($30M) | ($25M) | ($15M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $6M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $6M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | $3M | ($3M) | ($3M) | ($3M) | ($2M) | — |
| Net Income | $4M | $1M | ($5M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $24M | $30M | $28M | $47M | — |
| Total Liabilities | $22M | $37M | $15M | $9M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HCWB viewer.
About TickerBase · Data methodology & sources